Last Updated: August 14, 2026

CLINICAL TRIALS PROFILE FOR ANGIOTENSIN LL ACETATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ANGIOTENSIN LL ACETATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00239096 ↗ Prevention of Decompensation in Liver Cirrhosis Unknown status Else Poulsen Mindelegat Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
NCT00239096 ↗ Prevention of Decompensation in Liver Cirrhosis Unknown status Lundbeck Foundation Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
NCT00239096 ↗ Prevention of Decompensation in Liver Cirrhosis Unknown status University of Southern Denmark Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
NCT00239096 ↗ Prevention of Decompensation in Liver Cirrhosis Unknown status Odense University Hospital Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ANGIOTENSIN LL ACETATE

Condition Name

Condition Name for ANGIOTENSIN LL ACETATE
Intervention Trials
Alcoholic Liver Cirrhosis 1
Ascites 1
Cough 1
Haemodialyzed Patients 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ANGIOTENSIN LL ACETATE
Intervention Trials
Fibrosis 1
Cough 1
Ascites 1
Vascular Diseases 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ANGIOTENSIN LL ACETATE

Trials by Country

Trials by Country for ANGIOTENSIN LL ACETATE
Location Trials
United States 5
Denmark 1
Turkey 1
Romania 1
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ANGIOTENSIN LL ACETATE
Location Trials
North Carolina 1
New York 1
Missouri 1
Indiana 1
Colorado 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ANGIOTENSIN LL ACETATE

Clinical Trial Phase

Clinical Trial Phase for ANGIOTENSIN LL ACETATE
Clinical Trial Phase Trials
Phase 4 3
Phase 2 1
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ANGIOTENSIN LL ACETATE
Clinical Trial Phase Trials
Completed 4
Unknown status 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ANGIOTENSIN LL ACETATE

Sponsor Name

Sponsor Name for ANGIOTENSIN LL ACETATE
Sponsor Trials
Gulhane School of Medicine 2
Kasr El Aini Hospital 1
Else Poulsen Mindelegat 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ANGIOTENSIN LL ACETATE
Sponsor Trials
Other 10
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.